- Pfizer Inc. Chief Executive Officer Albert Bourla said that a key safety milestone had been reached in the study of its Covid-19 vaccine, and the drugmaker is now preparing to seek an emergency-use authorization from U.S. regulators.
- Moderna expects to get the safety data it needs by the end of the month, allowing it to file for emergency clearance in the coming weeks.
Pfizer Covid vaccine reaches key safety milestone, to seek emergency US FDA approval
